Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study Of Oral Etoposide In Combination With ORZEL (UFT + Leucovorin) For Advanced Non-Hematological Malignancies

NCT00009815 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00009815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00009815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study Of Oral Etoposide In Combination With ORZEL (UFT + Leucovorin) For Advanced Non-Hematological Malignancies
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Withdrawn
Start date
December 31, 1999
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific